Bio & Pharma
CG Bio establishes US corporation to develop tissue products
The company aims to prioritize the development of pre-market strategies. clinical trials and approvals
By Apr 25, 2023 (Gmt+09:00)
1
Min read
Most Read
Macquarie eyes its 1st Korean data center valued around $722 mn
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
S.Korea's LS Materials set to boost earnings ahead of IPO process
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
POSCO gears up for carbon-free steelmaking with hydrogen
![close](/images/ico/eyes/close.png)
![open](/images/ico/eyes/open.png)
![CG Bio establishes US corporation to develop tissue products](https://www.kedglobal.com/data/ked/image/2023/04/25/ked202304250037.700x.0.png)
South Korean bio-regenerative medical firm CG Bio has launched a new US corporation CG MedTech, to focus on the development and marketing of tissue products in North America, according to the company on Tuesday.
CG MedTech, which is fully owned by CG Bio, is headquartered in the state of Maryland, where the US Food and Drug Administration (FDA) is based. The company's research and production organization and sales and marketing organization are established in North Carolina and California, respectively. The subsidiary aims to prioritize the development of pre-market strategies and clinical trials and approvals.
CG Bio has also partnered with Wake Forest Institute for Regenerative Medicine (WFIRM) of Wake Forest University in North Carolina to develop 3D printing-based patient-specific solutions. CG MedTech has already received certification from the American Association of Tissue Banks, allowing the sale of human tissue skin products and bone products in the US market.
"CG MedTech will enable the company to expand its business in the North American market by developing products tailored to the needs of local customers," said CG Bio CEO Yoo Hyun-seung.
Write to Min-Su Han at hms@hankyung.com
More to Read
-
Beauty & CosmeticsS.Korea's CGBio exports $8 mn filler to Australia, New Zealand
Mar 24, 2023 (Gmt+09:00)
1 Min read -
Beauty & CosmeticsCGBio opens cosmetic surgery clinic in Bali using bio-medical tech
Mar 14, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaCGBio inks export deal for hyaluronic acid fillers with Chinese distributor
Mar 22, 2023 (Gmt+09:00)
1 Min read
Comment 0
LOG IN